Skip to main content
Veterinary Medicines

Addimag URA 160 mg/ml + 84 mg/ml oplossing voor infusie voor runderen

Authorised
  • Calcium gluconate monohydrate
  • Magnesium chloride hexahydrate

Product identification

Medicine name:
Addimag URA 160 mg/ml + 84 mg/ml oplossing voor infusie voor runderen
Active substance:
  • Calcium gluconate monohydrate
  • Magnesium chloride hexahydrate
Target species:
  • Cattle
Route of administration:
  • Intravenous use
  • Intravenous use

Product details

Active substance and strength:
  • Calcium gluconate monohydrate
    160.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    84.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        no withdrawal period
  • Intravenous use
    • Cattle
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 130341
Date of authorisation status change:
This information is not available for this product.

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 10/01/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."